Literature DB >> 19116340

Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

András Kern1, Gillian D Bryant-Greenwood.   

Abstract

We report here the desensitization and internalization of the relaxin receptor (RXFP1) after agonist activation in both primary human decidual cells and HEK293 cells stably transfected with RXFP1. The importance of beta-arrestin 2 in these processes has also been demonstrated. Thus, in HEK-RXFP1 cells the desensitization of RXFP1 was significantly increased when beta-arrestin 2 was overexpressed. After relaxin activation, beta-arrestin 2 was translocated to the cell membrane and RXFP1 underwent rapid internalization. We have previously shown that RXFP1 forms dimers/oligomers during its biosynthesis and trafficking to the plasma membrane, we now show that internalization of RXFP1 occurs through this dimerization/oligomerization. In nonagonist stimulated cells, it is known that the majority of the RXFP1 is located intracellularly and was confirmed in the cells used here. Constitutive internalization of RXFP1 could account for this and indeed, slow but robust constitutive internalization, which was increased after agonist stimulation was demonstrated. A carboxyl-terminal deleted RXFP1 variant had a similar level of constitutive agonist-independent internalization as the wild-type RXFP1 but lost sensitivity to agonist stimulation. This demonstrated the importance of the carboxyl terminus in agonist-stimulated receptor internalization. These data suggest that the autocrine/paracrine actions of relaxin in the decidua are under additional controls at the level of expression of its receptor on the surface of its target cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116340      PMCID: PMC2671891          DOI: 10.1210/en.2008-1385

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

Review 1.  Regulation of receptor trafficking by GRKs and arrestins.

Authors:  Catherine A C Moore; Shawn K Milano; Jeffrey L Benovic
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

2.  Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Authors:  Sabine Hombach-Klonisch; Joanna Bialek; Bogusz Trojanowicz; Ekkehard Weber; Hans-Jürgen Holzhausen; Josh D Silvertown; Alastair J Summerlee; Henning Dralle; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome.

Authors:  Janna E Slessareva; Sheri M Routt; Brenda Temple; Vytas A Bankaitis; Henrik G Dohlman
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

4.  Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules.

Authors:  Daniel J Scott; Sharon Layfield; Yan Yan; Satoko Sudo; Aaron J W Hsueh; Geoffrey W Tregear; Ross A D Bathgate
Journal:  J Biol Chem       Date:  2006-09-08       Impact factor: 5.157

5.  Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers.

Authors:  Marie C Smith; Lee A Danielson; Kirk P Conrad; John M Davison
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

6.  T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane.

Authors:  Natalia V Bogatcheva; Alberto Ferlin; Shu Feng; Anne Truong; Lisa Gianesello; Carlo Foresta; Alexander I Agoulnik
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

Review 7.  Relaxin in cardiovascular and renal disease.

Authors:  C S Samuel; T D Hewitson
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

8.  The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane.

Authors:  András Kern; Alexander I Agoulnik; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2006-12-07       Impact factor: 4.736

9.  Constitutive traffic of melanocortin-4 receptor in Neuro2A cells and immortalized hypothalamic neurons.

Authors:  Sameer Mohammad; Giovanna Baldini; Susana Granell; Paola Narducci; Alberto M Martelli; Giulia Baldini
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

10.  The human thyrotropin receptor is predominantly internalized by beta-arrestin 2.

Authors:  Romy Frenzel; Carsten Voigt; Ralf Paschke
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

View more
  16 in total

Review 1.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages.

Authors:  J S Horton; S Y Yamamoto; G D Bryant-Greenwood
Journal:  Biol Reprod       Date:  2011-07-06       Impact factor: 4.285

3.  Endoplasmic reticulum stress induced by oxidative stress in decidual cells: a possible mechanism of early pregnancy loss.

Authors:  Hui-Juan Gao; Yi-Min Zhu; Wei-Hua He; Ai-Xia Liu; Min-Yue Dong; Min Jin; Jian-Zhong Sheng; He-Feng Huang
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

4.  Primate preimplantation embryo is a target for relaxin during early pregnancy.

Authors:  Catherine A Vandevoort; Namdori R Mtango; Keith E Latham; Dennis R Stewart
Journal:  Fertil Steril       Date:  2011-06-08       Impact factor: 7.329

5.  Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis.

Authors:  William A Blessing; Stephen M Okajima; M Belen Cubria; Juan C Villa-Camacho; Miguel Perez-Viloria; Patrick M Williamson; Angie N Sabogal; Sebastian Suarez; Lay-Hong Ang; Suzanne White; Evelyn Flynn; Edward K Rodriguez; Mark W Grinstaff; Ara Nazarian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

Review 6.  Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.

Authors:  Alexander I Agoulnik; Irina U Agoulnik; Xin Hu; Juan Marugan
Journal:  Br J Pharmacol       Date:  2016-11-30       Impact factor: 8.739

Review 7.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Sub-picomolar relaxin signalling by a pre-assembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex.

Authors:  Michelle L Halls; Dermot M F Cooper
Journal:  EMBO J       Date:  2010-07-27       Impact factor: 11.598

9.  Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.

Authors:  Catherine Z Chen; Noel Southall; Jingbo Xiao; Juan J Marugan; Marc Ferrer; Xin Hu; Raisa E Jones; Shu Feng; Irina U Agoulnik; Wei Zheng; Alexander I Agoulnik
Journal:  J Biomol Screen       Date:  2012-12-04

10.  Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.

Authors:  Macarena Pampillo; Natasha Camuso; Jay E Taylor; Jacob M Szereszewski; Maryse R Ahow; Mateusz Zajac; Robert P Millar; Moshmi Bhattacharya; Andy V Babwah
Journal:  Mol Endocrinol       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.